Fast-Tracking Development of MSC-Based Cell and Extracellular Vesicle Therapies Through a Strategic Partnership
FUJIFILM Biotechnologies can help fast-track development of your MSC-Based Cell Therapies and Extracellular Vesicle Therapies Through our Strategic Partnership with RoosterBio.
Practical Considerations for your Sub-contracted Process Characterization (PC) Study
Subcontracting a Process Characterization (PC) study can be an expedient and practical undertaking for a biopharmaceutical company.
Enhanced Paveway™ PLUS Selects Expression Organisms Based on Titer Plus Quality
Launched in 2007, our core microbial expression system Paveway™ has offered industry leading titers by enabling lead strain selection based on product titer in six…
Paveway™ PLUS Microbial Expression System for the Efficient Production of Therapeutic Proteins
Paveway™ is an innovative expression system in Escherichia coli (E. coli) that enables the creation of novel recombinant strains where the lead strain selection is…
Advancing Cell and Gene Therapies Through Closed Aseptic Processes
Read about the benefits of closed aseptic processes in cell and gene therapy manufacturing.
Oncolytic Viruses Development and cGMP Manufacturing
FUJIFILM Biotechnologies offers preclinical, clinical, commercial GMP process development and manufacturing for oncolytic viruses, cancer viral vector vaccines and therapies in our global CDMO network.
The Changing Vaccine Development Landscape
Learn how the vaccines landscape is rapidly changing and what types of vaccines are now dominating the clinical development pipeline and biologics manufacturing.
Webinar: Biomanufacturing Strategies for Meeting Commercial Demand
Learn more with Biomanufacturing Strategies for Meeting Commercial Demand First Name(Required)Last Name(Required)Company Name(Required)Country(Required)United StatesUnited KingdomAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius...
An AAV Platform Advancing Successful Viral Vector Based Therapeutics
FUJIFILM Biotechnologies’ AAV platform is designed to support the timely and cost-effective development and manufacture of viral-based therapies.